Showing results (1-10 of 3) with videos related to
Sort By:
Pageof 1
Expert Opinion on Investigational Drugs|August 2, 2002
Iseganan HCl: a novel antimicrobial agentFrancis J Giles, Rebecca Redman, Salim Yazji, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Volociximab, a chimeric monoclonal antibody that specifically binds alpha5beta1 integrin: a phase I, pharmacokinetic, and biological correlative studyAlejandro D Ricart, Anthony W Tolcher, Glenn Liu, et al.Investigational New Drugs|July 18, 2016
A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumorsLee S Rosen, Patricia LoRusso, Wen Wee Ma, et al.Pageof 1